Titre:
  • Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II study.
Auteur:Van Laethem, Jean-Luc; Van Maele, Ph; Verslype, Chris; Polus, Marc; Demols, Anne; Houbiers, Ghislain; Caenepeel, P.; Leleux, A.; Vermaut, R R; Van Cutsem, Eric; Peeters, Marc
Informations sur la publication:Oncology, 67, 5-6, page (338-343)
Statut de publication:Publié, 2004
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adenocarcinoma -- drug therapy -- secondary
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Belgium
Deoxycytidine -- administration & dosage -- analogs & derivatives
Disease-Free Survival
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Pancreatic Neoplasms -- drug therapy -- pathology
Quinazolines -- administration & dosage
Survival Analysis
Thiophenes -- administration & dosage
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0030-2414
info:doi/10.1159/000082916
info:pii/82916
info:scp/13844307892
info:pmid/15713988